| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4d1f1996f857b76ad6927a62c7f37bcb |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-145
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-009
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-665
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-375 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-665
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-375 |
| filingDate |
2015-12-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_233d37015fb2b54da94bddc5e5faba9c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c0e4082915e593a4b81b4372aaa95220
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d9e56dfd5c9e01d75b19e2fa8f770e5a |
| publicationDate |
2018-12-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2018360855-A1 |
| titleOfInvention |
The formulation comprising phosphomycine and ascorbic acid for the treatment of bacterial urinary system infections |
| abstract |
The present invention is related to a pharmaceutical formulation in the form of a sachet which comprises ascorbic acid and phosphomycine trometamol, to be used in treating urinary system infections caused by pathogens sensitive to phosphomycine. The formulation is characterized in that phosphomycine is enabled to be more efficient in treating urinary system infections depending on the fact that ascorbic acid reduces the pH of urine. |
| priorityDate |
2015-12-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |